Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
silk suture
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
sodium iodide
United Therapeutics Europe Ltd
Transient Hypothyroxinemia
1 trial -
sodium valproate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Epilepsy
1 trial -
split-virion, adjuvanted H1N1 vaccine of 7.5 ΞΌg per dose
Sinovac Research and Development Co.,
Influenza
1 trial -
sublingual nicotine
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
tacrolimus
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Moderate/Severe Atopic Dermatitis
1 trial -
tasimelteon 20 mg capsule
Vanda Pharmaceuticals Netherlands B.V.
Non-24-Hour-Sleep-Wake Disorder
1 trial -
telbivudine (ROADMAP)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis B, Chronic
1 trial -
ticagrelor + ASA
Peking University Third Hospital
Cerebrovascular Accident
1 trial -
tong-jiang granules
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Non-erosive Reflux Disease/Diarrheal Irritable Bowel Syndrome
1 trial -
transdermal nicotine replacement therapy
BRIGHT MINDS BIOSCIENCES INC.
Smoking
1 trial -
treatment with CAZ-AVI
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Patients With Critically Ill Infections
1 trial -
trivalent seasonal influenza vaccine
Sinovac Research and Development Co.,
Influenza
1 trial -
turoctocog alfa
Novo Nordisk A/S
Congenital Bleeding Disorder
2 trials -
ulinastatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pancreatitis
1 trial -
vaccinated with Sabin IPV
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Polio
1 trial -
valdecoxib
Pfizer
Pain, Postoperative
1 trial -
video capsule endoscopy
Hospital Authority, Hong Kong
Overt Obscure Gastrointestinal Bleeding
1 trial -
vortioxetine
Takeda
Depression
1 trial -
0 ul of ondansetron
Hospital Authority, Hong Kong
Blood Coagulation Disorder
1 trial -
0.01% concentration atropine drops
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acupressure
1 trial -
0.1% bromfenac ophthalmic solution
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cataract
1 trial -
1.23% fluoride foam application
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Dental Caries in Children
1 trial -
10% N2O
BRIGHT MINDS BIOSCIENCES INC.
Opioid-Related Disorders
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources